RECENT NEWS 1 October 2012
Innovimmune profiled in BioCentury as Emerging Company
7 August 2012
Innovimmune featured in Xconomy

INNOVIMMUNE is a specialty Drug Discovery & Exploratory Development biotechnology company leading the development of novel first-in-class and best-in-class proprietary oral small molecule NME immunomodulatory drugs for the treatment of Autoimmune and ImmunoInflammatory Diseases.